Healthcare - Biotechnology - NASDAQ - US
$ 53.78
-2.92 %
$ 3.07 B
Market Cap
4.61
P/E
INCOME STATEMENT
26.8 M
REVENUE
-391 M
OPERATING INCOME
-352 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Agios Pharmaceuticals, Inc.
| Revenue | 26.8 M |
| Cost Of Revenue | 9.5 M |
| Gross Profit | 17.3 M |
| Operating Expenses | 409 M |
| Operating Income | -391 M |
| Other Expenses | -39.4 M |
| Net Income | -352 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||
| Revenue | 26.8 | 14.2 | 0 | 203.2 | 117.9 | 94.4 | 43.0 | 69.9 | 59.1 | 65.4 | 25.5 | 25.1 | 21.8 |
| GROSS PROFIT | |||||||||||||
| Cost Of Revenue | 9.5 | 1.7 | 18.8 | 2.8 | 1.3 | 1.4 | 292.7 | 220.2 | 141.8 | 100.4 | 54.5 | 41.0 | 0 |
| Gross Profit | 17.3 | 12.5 | (18.8) | 200.4 | 116.6 | 93.0 | (249.7) | (150.3) | (82.7) | (35.0) | (29.0) | (15.9) | 21.8 |
| OPERATING INCOME | |||||||||||||
| Operating Expenses | 408.8 | 401.6 | 378.4 | 516.5 | 542.9 | 455.5 | 363.8 | 270.9 | 177.8 | 119.5 | 64.4 | 48.1 | 38.5 |
| Selling, General and Administrative Expenses | 119.9 | 121.7 | 121.4 | 149.1 | 132.0 | 114.1 | 71.1 | 50.7 | 36.0 | 19.1 | 9.9 | 7.1 | 7.2 |
| Research and Development Expenses | 288.9 | 279.9 | 257.0 | 367.5 | 410.9 | 341.3 | 292.7 | 220.2 | 141.8 | 100.4 | 54.5 | 41.0 | 31.3 |
| Operating Income | (391.5) | (389.0) | (378.4) | (316.1) | (426.3) | (362.5) | (320.8) | (201.0) | (118.7) | (54.1) | (38.9) | (23.0) | (16.6) |
| PRE-TAX INCOME | |||||||||||||
| Interest Income Expense | 0 | 12.8 | 0 | 17.8 | 0 | 16.5 | 6.1 | 2.5 | 1.0 | 0.2 | 55 K | 69 K | 0.1 |
| Total Other Income | 39.4 | 157.2 | 21.9 | 6.6 | 14.9 | 16.5 | 6.1 | 2.5 | 1.0 | 0.2 | 55 K | 69 K | 0.1 |
| Pre-Tax Income | (352.1) | (231.8) | (356.5) | (327.4) | (411.5) | (346.0) | (314.7) | (198.5) | (117.7) | (53.9) | (38.8) | (22.9) | (16.5) |
| NET INCOME | |||||||||||||
| Tax Provision | 0 | (157.2) | (1 977.9) | 7.8 | (14.9) | 32.9 | (6.4) | (5.7) | (0.4) | (0.4) | 0.6 | (2.8) | 7.2 |
| Net Income | (352.1) | (74.6) | 1 604.7 | (335.2) | (396.6) | (346.0) | (314.7) | (198.5) | (117.7) | (53.5) | (39.4) | (20.1) | (23.7) |
| EPS | 6.33 | 1.36 | 26.6 | 4.86 | 6.61 | 6.03 | 6.75 | 5.07 | 3.15 | 1.59 | 2.56 | 0.86 | 1.01 |